Skip to main content
. 2021 Jun 9;8:668534. doi: 10.3389/fmolb.2021.668534

FIGURE 2.

FIGURE 2

ROC curve analysis depicting the performance of a 4-miRNA panel consisted of miR-19a, miR-20a, miR-126, and miR-155 to distinguish early from metastatic breast cancer patients. AUC, area under curve.